Redeye: NeoDynamics - Cash in the Bank but Slower Sales Ramp-up
Redeye returns with a more in-depth take on NeoDynamics following the Q1 report. In this update, we re-consider our financial projections on the basis of a prolonged US launch and slower market ramp-up in the EU than previously anticipated. Accordingly, we lower our Fair Value Range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/